Healthcare >> CEO Interviews >> October 4, 1999
ANDERS HOVE is manager of BB Biotech and a partner of Bellevue Holding
AG. BB Biotech is a Swiss based biotechnology investment company with
total assets of more than CHF 2,000 million. From 1992 to 1996 Dr. Hove
was employed at the Pharmaceuticals Division of Ciba-Geigy in Basel,
Switzerland, initially in the International Medicines and Clinical
Development Department and later in Business Operations and Strategic
Marketing functions. Dr. Hove received a MSc in Chemical Engineering
(biotechnology) from the Technical University of Denmark, a MD from the
Medical School of the University of Copenhagen and a MBA from INSEAD,
Fontainebleau, France. Profile
TWST: Can you please give us a brief overview of BB Biotech - thecompany's history, activities, etc.
Mr. Hove: BB Biotech was founded in November 1993 as a Swiss-based
investment company. The